Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways

Chronic pain is a debilitating condition affecting millions worldwide, often resulting from complex interactions between the nervous and immune systems. Recent advances highlight the critical role of metabolite-sensing G protein-coupled receptors (GPCRs) in various chronic pain types. These receptor...

Full description

Saved in:
Bibliographic Details
Main Authors: Ciprian Pușcașu, Corina Andrei, Octavian Tudorel Olaru, Anca Zanfirescu
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/1/63
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588781727776768
author Ciprian Pușcașu
Corina Andrei
Octavian Tudorel Olaru
Anca Zanfirescu
author_facet Ciprian Pușcașu
Corina Andrei
Octavian Tudorel Olaru
Anca Zanfirescu
author_sort Ciprian Pușcașu
collection DOAJ
description Chronic pain is a debilitating condition affecting millions worldwide, often resulting from complex interactions between the nervous and immune systems. Recent advances highlight the critical role of metabolite-sensing G protein-coupled receptors (GPCRs) in various chronic pain types. These receptors link metabolic changes with cellular responses, influencing inflammatory and degenerative processes. Receptors such as free fatty acid receptor 1 (FFAR1/GPR40), free fatty acid receptor 4 (FFAR4/GPR120), free fatty acid receptor 2 (FFAR2/GPR43), and Takeda G protein-coupled receptor 5 (TGR5/GPR131/GPBAR1) are key modulators of nociceptive signaling. GPR40, activated by long-chain fatty acids, exhibits strong anti-inflammatory effects by reducing cytokine expression. Butyrate-activated GPR43 inhibits inflammatory mediators like nitric oxide synthase-2 and cyclooxygenase-2, mitigating inflammation. TGR5, activated by bile acids, regulates inflammation and cellular senescence through pathways like NF-κB and p38. These receptors are promising therapeutic targets in chronic pain, addressing the metabolic and inflammatory factors underlying nociceptive sensitization and tissue degeneration. This review explores the molecular mechanisms of metabolite-sensing receptors in chronic pain, their therapeutic potential, and challenges in clinical application. By uncovering these mechanisms, metabolite-sensing receptors could lead to safer, more effective pain management strategies.
format Article
id doaj-art-887cccaa4f0841edbff2f3ddf55c72b0
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-887cccaa4f0841edbff2f3ddf55c72b02025-01-24T13:27:36ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-01-014716310.3390/cimb47010063Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain PathwaysCiprian Pușcașu0Corina Andrei1Octavian Tudorel Olaru2Anca Zanfirescu3Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, RomaniaFaculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, RomaniaFaculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, RomaniaFaculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, RomaniaChronic pain is a debilitating condition affecting millions worldwide, often resulting from complex interactions between the nervous and immune systems. Recent advances highlight the critical role of metabolite-sensing G protein-coupled receptors (GPCRs) in various chronic pain types. These receptors link metabolic changes with cellular responses, influencing inflammatory and degenerative processes. Receptors such as free fatty acid receptor 1 (FFAR1/GPR40), free fatty acid receptor 4 (FFAR4/GPR120), free fatty acid receptor 2 (FFAR2/GPR43), and Takeda G protein-coupled receptor 5 (TGR5/GPR131/GPBAR1) are key modulators of nociceptive signaling. GPR40, activated by long-chain fatty acids, exhibits strong anti-inflammatory effects by reducing cytokine expression. Butyrate-activated GPR43 inhibits inflammatory mediators like nitric oxide synthase-2 and cyclooxygenase-2, mitigating inflammation. TGR5, activated by bile acids, regulates inflammation and cellular senescence through pathways like NF-κB and p38. These receptors are promising therapeutic targets in chronic pain, addressing the metabolic and inflammatory factors underlying nociceptive sensitization and tissue degeneration. This review explores the molecular mechanisms of metabolite-sensing receptors in chronic pain, their therapeutic potential, and challenges in clinical application. By uncovering these mechanisms, metabolite-sensing receptors could lead to safer, more effective pain management strategies.https://www.mdpi.com/1467-3045/47/1/63chronic painmetaboliteslong-chain fatty acidsinflammation
spellingShingle Ciprian Pușcașu
Corina Andrei
Octavian Tudorel Olaru
Anca Zanfirescu
Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
Current Issues in Molecular Biology
chronic pain
metabolites
long-chain fatty acids
inflammation
title Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
title_full Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
title_fullStr Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
title_full_unstemmed Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
title_short Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways
title_sort metabolite sensing receptors emerging targets for modulating chronic pain pathways
topic chronic pain
metabolites
long-chain fatty acids
inflammation
url https://www.mdpi.com/1467-3045/47/1/63
work_keys_str_mv AT ciprianpuscasu metabolitesensingreceptorsemergingtargetsformodulatingchronicpainpathways
AT corinaandrei metabolitesensingreceptorsemergingtargetsformodulatingchronicpainpathways
AT octaviantudorelolaru metabolitesensingreceptorsemergingtargetsformodulatingchronicpainpathways
AT ancazanfirescu metabolitesensingreceptorsemergingtargetsformodulatingchronicpainpathways